Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.
about
Management of sexual dysfunction due to central nervous system disorders: a systematic reviewSexual health outcome measures for individuals with a spinal cord injury: a systematic review.A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction.Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis.Measurement of sexual functioning after spinal cord injury: preferred instruments.Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil.Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years.Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
P2860
Q26863071-4D8CF7E8-6856-4818-BB56-9DE2FF832606Q34701330-9D2110BA-29B9-4D5B-9D08-AE1773BD9BF7Q35628328-4C083565-C63D-4B2C-87BC-84F4A5EC6760Q37074999-F95D32C7-7397-41CA-A469-25CE858E3A42Q37283867-48F211B5-DF8C-43D5-8D6B-4299C2C2920BQ42609456-823C0502-1FC1-4ED0-A45C-5C0003B04572Q44968030-4786E2D3-5922-4433-9C47-089A8C38758EQ45964628-CBDC7F94-E022-4D9A-BACF-37624766B07CQ46255315-84BE5ACA-92CD-49E1-A87F-EB393381F79C
P2860
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
type
label
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
prefLabel
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
Efficacy and safety of tadalaf ...... l noninferiority study design.
@nl
P2093
P1476
Efficacy and safety of tadalaf ...... l noninferiority study design.
@en
P2093
Abraham Morgentaler
Carmen S Garcia
Craig Donatucci
David G Wong
Fanni Natanegara
James Barada
Sanjeev Ahuja
P304
P356
10.1111/J.1743-6109.2006.00209.X
P577
2006-05-01T00:00:00Z